Not just another IPC bulletin…
It’s 11 am on the ward, and you’ve just sat down at your computer after the round and made the mistake of opening your email inbox.
They say that only three things in life are certain: death, taxes and spam emails. Your manual handling e-learning is overdue, there’s a problem with the electronic prescribing system, your ward office chairs have been deemed unsafe…
There it is, another neglected IPC notification. Something called WAAW? Not very catchy, but trust me, give it a chance.
So what is WAAW?
World AMR Awareness Week (WAAW) is a WHO campaign that takes place every year, 18-24 November, and was established in 2015.
It has two main goals: to raise awareness of the significance of antimicrobial resistance (AMR) and to encourage people worldwide to address drug-resistant infections.
It’s important to remember that AMR doesn’t only concern antibiotics; it also applies to antivirals, antifungals, and antiparasitics, even though our focus generally tends to be centred on bacterial infections.
WAAW is a call to action. Stakeholders at every level are called to make one ‘meaningful action’ to do their bit during this WAAW, with suggestions listed in the WHO campaign guide.
Over the course of WAAW, the UK focuses on the 4 themes of its 5-year national action plan, namely:
- ‘Reducing the need for, and unintentional exposure to, antimicrobials
- Optimising the use of antimicrobials
- Investing in innovation, supply and access
- Being a good global partner’
This year’s theme is ‘One Health, One Action: Prevent AMR now’, drawing attention towards the One Health model and the importance of prevention rather than cure. After all, no infection in the first place means no need for antibiotics. The One Health model emphasises working beyond the borders of human vs animal healthcare to respond effectively to public health threats. This can include sharing One Health-focused information in medical education, developing communication channels, working in partnership across sectors, and empowering the public through outreach.
As much as our colleagues in adult medicine may disagree, paediatrics is not the same as veterinary medicine. However, the One Health model remains very relevant to us, and this year’s WAAW aims to champion it.
And why should I care?
Here’s the scary thing: AMR is already an established threat, not just a problem for the distant future. Despite a decrease during the COVID pandemic in 2020-2021, there has since been a year-on-year increase in antibiotic-resistant bacteraemia in the UK, with a 9.3% rise between 2023 and 2025.
One systematic analysis published in The Lancet predicts that in 2050, there will be 1.91 million global deaths directly caused by AMR and a further 8.22 million deaths associated with AMR, based on data from 1990-2021. This same study found that, during this period, AMR mortality decreased in all super-regions for children younger than 5, while increasing for people aged 5 and older, with an 80% increase among those aged 70 and older.
The authors link the reduction in mortality among young children to a reduction in infections with vaccination and better access to clean water and sanitation, highlighting the importance of good infection prevention in tackling AMR- the simplest things really do have some of the biggest impacts. AMR is still a major concern even for this under-5 group since, worryingly, the proportion of sepsis deaths associated with AMR in this age group has increased relative to 1990.
Health inequalities are a significant problem in AMR. In England, the rate of antibiotic-resistant bacteraemia is 47.2% higher in more deprived areas than in the least deprived areas, a gap that has widened since 2019. Moreover, AMR has a disproportionate burden in low- and middle-income countries, where different driving factors than in developed countries create a need for different strategies to address the problem. This leaves socio-economically disadvantaged children worldwide at increased risk of AMR.
Not only is AMR a population-level threat, but unnecessary antibiotic exposure also has direct impacts on the children we treat. Like all drugs, we are aware that antibiotics have side effects of their own and overuse of broad-spectrum antibiotics harms the gut flora, leading to gastrointestinal complications.
Antibiotic exposure in children has been associated with increased risk of long-term conditions ranging from atopic dermatitis to neurodevelopmental disorders. The RCPCH recommends taking time to further assess a child without septic shock to narrow antibiotic therapy and avoid overuse of broad-spectrum antibiotics.
Good antimicrobial stewardship benefits both the child in front of you and the population as a whole.
What can I do?
The main goal of WAAW is simple: spreading awareness about AMR. It’s easy to think of AMR as a distant problem, especially amid decision fatigue and constant pressure to meet a whole host of clinical targets. However, we need to do more than bury our heads in the sand to tackle the threat of AMR.
Firstly, think small. WAAW highlights AMR at one point in the year, but small, sustainable changes have a big impact if you stick with them over time. Remember your IPC basics and stay militant with good hygiene; handwashing is one of the greatest tools in our arsenal, even if that message has been done to death. Use your local antibiotic prescribing guidelines even for ‘basic’ infections, and consider entering the world of allergy de-labelling where appropriate. Penicillin allergy de-labelling can be trialled safely and effectively within the paediatric emergency department, allowing wider use of first-line antibiotics for many infections.
The UKHSA has put together a toolkit on evidence-based antimicrobial stewardship practice in inpatient settings with the message ‘start smart then focus (SSTF)’. A key part of the ‘focus’ aspect is reviewing antimicrobials after 48-72 hours of treatment and deciding whether to cease, amend, refer, extend or switch antimicrobial therapy. Simple frameworks like this provide the foundations of evidence-based decision-making.
The CAP-IT trial, looking at amoxicillin prescribing in children with community-acquired pneumonia, highlights the value of challenging our ideas about antibiotic treatment with evidence. This trial studied children with community-acquired pneumonia discharged from the emergency department or paediatric ward within 48 hours and found that lower-dose oral amoxicillin is noninferior to higher-dose treatment, and a 3-day course is noninferior to a 7-day course for outpatient management. Emerging research like this gives us the tools to make evidence-based antimicrobial decisions for our paediatric population.
If you want to go one step further, think about how you can address AMR in your local department. This could be in the form of quality improvement projects or department education.

“Hey guys, I saw this great article on World AMR Awareness Week on DFTB today, you should totally take a look!”
Just kidding (no, I’m not). Seriously though, think about how many children receive antibiotics in hospital. A culture shift in one department that makes the team more AMR-aware can benefit countless individual patients and their families.
Ultimately, AMR is a public health concern which needs work at all levels. Even though we are all accountable, our actions mean little without coordinated efforts across regions and nations. Global participation in WAAW keeps the conversation going via new initiatives in different settings and the chance to attend a range of events organised by national and international organisations. Looking further ahead, the UK has committed to a second 5-year national action plan for 2024-2029 as part of the UK 20-year vision for antimicrobial resistance (3).
I want to find out more!
Here are some helpful resources to build your understanding of AMR, what’s happening this World AMR Awareness Week, and how you can get involved.
WHO AMR fact sheet https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
WHO WAAW 2026 campaign guide https://www.who.int/publications/m/item/world-amr-awareness-week-2026—campaign-guide
Learn more about AMR survivors’ testimonies via the WHO Task Force of AMR Survivors https://www.who.int/groups/task-force-of-amr-survivors
UNICEF’s World Children’s Day falls within WAAW on 20th November 2026 and there are a range of events planned to mark this intersection listed on the WHO events page https://www.who.int/campaigns/world-amr-awareness-week/world-amr-awareness-week-2026/waaw-events.
UK Paediatric Antimicrobial Stewardship (UK-PAS) network https://uk-pas.co.uk/
UKHSA ‘Start Smart Then Focus’ toolkit for inpatient use https://www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus/start-smart-then-focus-antimicrobial-stewardship-toolkit-for-inpatient-care-settings
The Bottom Line
World AMR Awareness Week is for everyone, everywhere
AMR is a global child health threat which needs urgent action
Every individual can make a difference; start small with things like hand hygiene and reviewing all antimicrobials after 48-72 hours
There are plenty of resources available for education and ideas about how to address AMR in your own department
References
World Health Organization. World AMR Awareness Week 2026 [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Oct 28]. Available from: https://www.who.int/news-room/events/detail/2026/11/18/default-calendar/world-amr-awareness-week-2026
World Health Organization. World AMR Awareness Week 2026: campaign guide [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Oct 28]. Available from: https://cdn.who.int/media/docs/default-source/waaw-2026/world-amr-awareness-week-2026-campaign-guide.pdf
Department of Health and Social Care, Scottish Government, Welsh Government, Department for Environment, Food & Rural Affairs, Department of Agriculture, Environment and Rural Affairs (Northern Ireland), Department of Health (Northern Ireland). UK 5-year action plan for antimicrobial resistance 2024 to 2029 [Internet]. London: GOV.UK; 2024 May 8 [cited 2026 Oct 28]. Available from: https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2024-to-2029
Mackenzie JS, Jeggo M. The One Health approach—why is it so important? Trop Med Infect Dis. 2019;4(2):88. doi:10.3390/tropicalmed4020088.
Machalaba C, Raufman J, Anyamba A, Berrian AM, Berthe FCJ, Gray GC, et al. Applying a One Health approach in global health and medicine: enhancing involvement of medical schools and global health centers. Ann Glob Health. 2021;87(1):30. doi:10.5334/aogh.2647.
UK Health Security Agency. ESPAUR report 2024 to 2025: lay summary [Internet]. London: UK Health Security Agency; 2026 May 13 [cited 2026 Oct 28]. Available from: https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur-2024-to-2025-report/espaur-report-2022-to-2023-lay-summary
Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226. doi:10.1016/S0140-6736(24)01867-1.
Ehsan H. Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Chall. 2025;4(1):e70034. doi:10.1002/puh2.70034.
Fuller C, Patel S. Safety considerations of antibiotic choice and route in children – patient safety spotlight [Internet]. London: Royal College of Paediatrics and Child Health; 2026 Feb 20 [cited 2026 Oct 28]. Available from: https://www.rcpch.ac.uk/news-events/news/2026-02/safety-considerations-antibiotic-choice-route-children-patient-safety
Duong QA, Pittet LF, Curtis N, Zimmermann P. Antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis. J Infect. 2022;85(3):213–300. doi:10.1016/j.jinf.2022.01.005.
Hibberd O, Karageorgos S, Ranaweera M, Mullally PJW, Constantin MV, Byrne A, et al. De-labelling penicillin allergies in the paediatric emergency department. Antibiotics (Basel). 2025;14(12):1222. doi:10.3390/antibiotics14121222.
UK Health Security Agency. Start smart then focus: antimicrobial stewardship toolkit for inpatient care settings [Internet]. London: UK Health Security Agency; 2023 Sep 12 [cited 2026 Oct 28]. Available from: https://www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus/start-smart-then-focus-antimicrobial-stewardship-toolkit-for-inpatient-care-settings
Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, et al. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA. 2021;326(17):1713-24. doi:10.1001/jama.2021.17843.











